Мы используем файлы cookie.
Продолжая использовать сайт, вы даете свое согласие на работу с этими файлами.
Methallylescaline
Другие языки:

    Methallylescaline

    Подписчиков: 0, рейтинг: 0
    Methallylescaline
    Methallylescaline.svg
    Names
    Preferred IUPAC name
    2-{3,5-Dimethoxy-4-[(2-methylprop-2-en-1-yl)oxy]phenyl}ethan-1-amine
    Identifiers
    3D model (JSmol)
    ChEMBL
    ChemSpider
    PubChem CID
    UNII
    • InChI=1S/C14H21NO3/c1-10(2)9-18-14-12(16-3)7-11(5-6-15)8-13(14)17-4/h7-8H,1,5-6,9,15H2,2-4H3 checkY
      Key: FOXJFBFFGULACD-UHFFFAOYSA-N checkY
    • InChI=1/C14H21NO3/c1-10(2)9-18-14-12(16-3)7-11(5-6-15)8-13(14)17-4/h7-8H,1,5-6,9,15H2,2-4H3
      Key: FOXJFBFFGULACD-UHFFFAOYAG
    • CC(=C)COc1c(cc(cc1OC)CCN)OC
    Properties
    C14H21NO3
    Molar mass 251.326 g·mol−1
    Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
    checkY verify (what is checkY☒N ?)

    Methallylescaline (4-Methylallyloxy-3,5-dimethoxyphenethylamine) is a lesser-known psychedelic drug. It is the 4-methyl analog of allylescaline. Methallylescaline was first synthesized by Alexander Shulgin. In his book PiHKAL, the dosage range is listed as 40–65 mg and the duration is listed as 12–16 hours. Little data exists about the pharmacological properties, metabolism, and toxicity of methallylescaline, though it is known to be an agonist of 5-HT2A receptors, and has been sold as a designer drug.

    Legal status

    Methallylescaline is illegal in Sweden as of 26 January 2016.

    See also



    Новое сообщение